Psychoneuroimmunology Archives

Neuroimaging Updates In Schizophrenia & The Future Of Precision Medicine: An Interview With Dr. Anissa Abi-Dargham

Video June 15, 2021

Dr. Anissa Abi-Dargham will provide updates on the use of neuroimaging in Schizophrenia. She will focus on the recent findings on various neurotransmitter systems including Dopamine, Glutamate, and GABA (gamma… Read More

Psychoneuroimmunology: Mood Disorders Part 2 In PNI Series

Video March 23, 2020

Drs. Rachel Self, Carolyn Tyler, and Heather Davidson provide an understanding of the immune system and neuroinflammation and their impact on mood disorders. Topics covered in part two of this… Read More

Psychoneuroimmunology: Immune System & Neuroinflammation Basics Part 1 In PNI Series

Video March 16, 2020

In a three-part series for PsychU, Drs. Rachel Self, Carolyn Tyler and Heather Davidson discuss the immune system and neuroinflammation. Part one will discuss inflammatory response in the brain, potential… Read More

Revisiting Cognitive Deficits In Bipolar Disorder

On-Demand Webinar June 11, 2019

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, verbal learning and memory, and executive functions, including working memory… Read More

The Role Of Glutamate In Mood Disorders & Schizophrenia

On-Demand Webinar March 19, 2019

Glutamate is the predominant excitatory neurotransmitter in the nervous system, and glutamatergic dysregulation has been implicated in the pathophysiology of both mood disorders and schizophrenia. In this webinar, Dr. James… Read More

Webinar Summary – Gender Differences In Depression

Article March 7, 2019

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/gender-differences-in-depression/. On March 7, 2019,… Read More

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

On-Demand Webinar October 9, 2018

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading cause of disability globally. Current treatment strategies for depression are… Read More

Webinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

Article October 9, 2018

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/evolving-pharmacology-depression-beyond-monoamine-hypothesis/. On October 9, 2018,… Read More

Neuromodulation Techniques: State Of The Science

On-Demand Webinar July 11, 2018

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, adherence, safety, and medication tolerability. Currently available pharmacotherapeutic, psychotherapeutic, and… Read More

The Gut-Brain Axis: An Interview With Roger McIntyre, MD, FRCPC

Interview April 23, 2018

In this interview, Roger McIntyre, MD, FRCPC, Professor of Psychiatry & Pharmacology at the University of Toronto, Head of the Mood Disorders Psychopharmacology Unit at University Health Network, and Executive… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: